A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method.
COVID-19
SARS-CoV-2 detection
molecular diagnosis
saliva testing
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
02 02 2022
02 02 2022
Historique:
received:
05
01
2022
revised:
24
01
2022
accepted:
31
01
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
9
3
2022
Statut:
epublish
Résumé
Efficient, wide-scale testing for SARS-CoV-2 is crucial for monitoring the incidence of the infection in the community. The gold standard for COVID-19 diagnosis is the molecular analysis of epithelial secretions from the upper respiratory system captured by nasopharyngeal (NP) or oropharyngeal swabs. Given the ease of collection, saliva has been proposed as a possible substitute to support testing at the population level. Here, we used a novel saliva collection device designed to favour the safe and correct acquisition of the sample, as well as the processivity of the downstream molecular analysis. We tested 1003 nasopharyngeal swabs and paired saliva samples self-collected by individuals recruited at a public drive-through testing facility. An overall moderate concordance (68%) between the two tests was found, with evidence that neither system can diagnose the infection in 100% of the cases. While the two methods performed equally well in symptomatic individuals, their discordance was mainly restricted to samples from convalescent subjects. The saliva test was at least as effective as NP swabs in asymptomatic individuals recruited for contact tracing. Our study describes a testing strategy of self-collected saliva samples, which is reliable for wide-scale COVID-19 screening in the community and is particularly effective for contact tracing.
Identifiants
pubmed: 35215902
pii: v14020313
doi: 10.3390/v14020313
pmc: PMC8878650
pii:
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Diseases. 2021 May 20;9(2):
pubmed: 34065171
EBioMedicine. 2020 Sep;59:102960
pubmed: 32853988
N Engl J Med. 2020 May 28;382(22):e76
pubmed: 32302471
Nat Rev Genet. 2021 Jul;22(7):415-426
pubmed: 33948037
Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):447-450
pubmed: 33236269
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
BMC Infect Dis. 2021 May 28;21(1):496
pubmed: 34049515
Med. 2022 Apr 8;3(4):262-268.e4
pubmed: 35313451
J Infect. 2020 Sep;81(3):e48-e50
pubmed: 32593658
Ann Intern Med. 2022 May;175(5):682-690
pubmed: 35286144
Oral Dis. 2022 Nov;28 Suppl 2:2347-2361
pubmed: 34080272
J Pathol. 2021 Jul;254(3):239-243
pubmed: 33834497
Nat Rev Microbiol. 2021 Mar;19(3):171-183
pubmed: 33057203
Lancet Infect Dis. 2020 Apr;20(4):411-412
pubmed: 32105638
Sci Rep. 2021 Feb 4;11(1):3134
pubmed: 33542443
Lancet Respir Med. 2021 Jun;9(6):562-564
pubmed: 33887248
Emerg Infect Dis. 2021 Apr;27(4):1146-1150
pubmed: 33754989
Int J Infect Dis. 2021 Jan;102:299-302
pubmed: 33130202
Nature. 2022 Mar;603(7902):687-692
pubmed: 35062015
Clin Infect Dis. 2020 Jul 28;71(15):841-843
pubmed: 32047895
BMC Infect Dis. 2022 Mar 25;22(1):284
pubmed: 35337266
BDJ Open. 2021 Jan 26;7(1):8
pubmed: 33500385
J Dent Res. 2020 Sep;99(10):1120-1121
pubmed: 32479133